The FDA designates ARB1002 as an orphan drug, highlighting its potential as a novel treatment for pancreatic cancer amid ...

A new study explains how pancreatic tumors use a sugar coating to hide from the immune system and shows that a newly ...

New subgroup analysis shows consistent, clinically meaningful pain reduction observed from Stage 2 through Stage 4 disease, including late-stage ...

Irene Blair was expected to have another six to eight months to live in June, after her pancreatic cancer rapidly advanced to ...

Partner Therapeutics, Inc. (PTx), a private, fully integrated biotechnology company, announced new data from a post hoc analysis of the eNRGy trial (NCT02912949), evaluating zenocutuzumab in patients ...

Dan, a pancreatic cancer survivor and advocate, shared insights on participating in clinical trials and the importance of ...

Arbele, a biotechnology company focused on developing innovative targeted cancer therapies, today announced that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation (ODD) ...

Autonomix Medical is focused on developing precision nerve-targeted treatments using a transvascular RF denervation platform. The company’s approach aims to address pancreatic cancer pain, which ...

Pancreatic cancer is one of the most difficult cancers to treat and is a leading cause of cancer-related deaths. Now, Sidney Kimmel Cancer Center - Jefferson Health and Lankenau Institute for Medical ...

Despite being diagnosed with what he himself referred to as a "death sentence," the former U.S. senator declared that he's ...